K252a

K252a
Names
IUPAC name
(9S-(9α,10β,12α))-2,3,9,10,11,12-hexahydro-10-hydroxy-10-(methoxycarbonyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one
Identifiers
99533-80-9 N
ChEMBL ChEMBL281948 N
ChemSpider 2299962 N
ECHA InfoCard 100.167.781
336
PubChem 3035817
UNII IV7H45AM5B YesY
Properties[1]
C27H21N3O5
Molar mass 467.48 g·mol−1
Solubility in other solvents Soluble in DMSO, dichloromethane, and methanol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YesYN ?)
Infobox references

K252a is an alkaloid isolated from Nocardiopisis sp. soil fungi. This staurosporine analog is a highly potent cell permeable inhibitor of CaM kinase and phosphorylase kinase (IC50 = 1.8 and 1.7 nmol/L, respectively). At higher concentrations it is also an efficient inhibitor of serine/threonine protein kinases (IC50 of 10 to 30 nmol/L).[2][3][4][5][6][7][8][9]

K252a is reported to promote myogenic differentiation in C2 mouse myoblasts[6] and has been shown to block the neuronal differentiation of rat pheochromocytoma PC12 cells by inhibition of trk tyrosine kinase activity.[10]

K252a has been reported in preclinical research as a potential treatment for psoriasis.

K252a inhibits tyrosine phosphorylation of Trk A induced by NGF. PC12 cells were incubated in the presence or absence of 10 ng/ml NGF with or without various concentrations of K252a.

See also

References

  1. K252a from Fermentek
  2. Ruegg, U.T. et al. (1989) Tips 10, 218.
  3. Eliot, L.H. et al. (1990) B.B.R.C. 171, 148.
  4. Simpson, D.l. et al. (1991) J. Neurosci. Res, 28, 148.
  5. Chin, L.S. et al. (1999) Cancer Invest. 17, 391.
  6. 1 2 Tapley, P. et al. (1992) Oncogene 7, 371.
  7. Hashimoto, S. (1998) J. Cell Biol. 107, 1531.
  8. Kase, H. et al. (1987) B.B.R.C. 142, 436.
  9. Hirayama E. et al. (2001) B.B.R.C. 285, 1237.
  10. Borasio, G.D. Neurosci. Lett. (1990) 108, 207.

Further reading



This article is issued from Wikipedia - version of the 5/30/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.